Jubilant Ingrevia Limited
NSE:JUBLINGREA.NS
775.55 (INR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 10,243.4 | 10,744.4 | 9,604.5 | 10,111 | 10,686.6 | 11,294.8 | 11,526.3 | 12,989.8 | 11,593.9 | 12,758.72 | 12,830.1 | 12,170.7 | 11,384.8 | 6,789.69 | -6,789.7 | 11,384.8 |
| Cost of Revenue
| 7,868.8 | 8,351.7 | 5,086 | 5,052.7 | 5,502.2 | 6,478.8 | 6,098.9 | 7,146.2 | 6,091.8 | 8,989.09 | 7,344.9 | 7,222.3 | 5,794.3 | 0 | 0 | -5,794.3 |
| Gross Profit
| 2,374.6 | 2,392.7 | 4,518.5 | 5,058.3 | 5,184.4 | 4,816 | 5,427.4 | 5,843.6 | 5,502.1 | 3,769.63 | 5,485.2 | 4,948.4 | 5,590.5 | 6,789.69 | -6,789.7 | 17,179.1 |
| Gross Profit Ratio
| 0.232 | 0.223 | 0.47 | 0.5 | 0.485 | 0.426 | 0.471 | 0.45 | 0.475 | 0.295 | 0.428 | 0.407 | 0.491 | 1 | 1 | 1.509 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 1,526.95 | 0 | 0 | 0 | 837.19 | 0 | 0 | 0 | 63.785 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 60.35 | 0 | 0 | 0 | 9.08 | 0 | 0 | 0 | 213.05 | 0 | 0 |
| SG&A
| 1,668.1 | 1,837.5 | 1,500.7 | 1,604.2 | 934.4 | 1,587.3 | 1,358 | 1,550.1 | 821.5 | 846.27 | 883.1 | 758.7 | 1,190.9 | 276.835 | 0 | 0 |
| Other Expenses
| 95.7 | 95 | 87.8 | 85.2 | 85 | 90 | 70 | 72.9 | 100.8 | 79.96 | 93.6 | 69.6 | 59.8 | 1,514.927 | 2,242.858 | 59.8 |
| Operating Expenses
| 1,668.1 | 1,837.5 | 3,905.2 | 4,220.8 | 4,340.9 | 4,093.9 | 4,214.4 | 4,624.3 | 4,406.9 | 2,398.6 | 3,661.5 | 3,301.1 | 3,091.6 | 1,791.762 | 2,242.858 | -3,213.2 |
| Operating Income
| 706.5 | 555.2 | 701.4 | 923.9 | 843.5 | 812.2 | 1,282.9 | 1,291.8 | 1,095.2 | 1,371.03 | 1,823.7 | 1,647.3 | 1,917.2 | 950.658 | -1,161.258 | 2,618.6 |
| Operating Income Ratio
| 0.069 | 0.052 | 0.073 | 0.091 | 0.079 | 0.072 | 0.111 | 0.099 | 0.094 | 0.107 | 0.142 | 0.135 | 0.168 | 0.14 | 0.171 | 0.23 |
| Total Other Income Expenses Net
| -47 | -41.2 | -150.6 | -125.2 | -30.4 | -57 | -66.9 | -51 | 59.9 | -225.92 | 45 | -2.2 | -48.5 | -176.73 | 387.3 | -188.1 |
| Income Before Tax
| 659.5 | 514 | 550.8 | 798.7 | 813.1 | 755.2 | 1,216 | 1,240.8 | 1,155.1 | 1,145.11 | 1,868.7 | 1,645.1 | 2,430.5 | 773.928 | -773.958 | 2,430.5 |
| Income Before Tax Ratio
| 0.064 | 0.048 | 0.057 | 0.079 | 0.076 | 0.067 | 0.105 | 0.096 | 0.1 | 0.09 | 0.146 | 0.135 | 0.213 | 0.114 | 0.114 | 0.213 |
| Income Tax Expense
| 172.9 | 221 | 165.2 | 223.8 | 237.2 | 232.1 | 300.7 | 398 | 361.3 | 459.2 | 578 | 537.2 | 747.9 | 230.28 | 230.3 | -747.9 |
| Net Income
| 487.4 | 292.5 | 385.6 | 574.9 | 575.9 | 523.07 | 915.3 | 842.8 | 793.8 | 685.91 | 1,290.7 | 1,107.9 | 1,682.6 | 543.648 | -543.658 | 1,682.6 |
| Net Income Ratio
| 0.048 | 0.027 | 0.04 | 0.057 | 0.054 | 0.046 | 0.079 | 0.065 | 0.068 | 0.054 | 0.101 | 0.091 | 0.148 | 0.08 | 0.08 | 0.148 |
| EPS
| 3.06 | 1.85 | 2.43 | 3.62 | 3.62 | 3.28 | 5.75 | 5.31 | 4.99 | 4.31 | 8.12 | 6.97 | 10.58 | 3.42 | -3.42 | 10.56 |
| EPS Diluted
| 3.06 | 1.85 | 2.43 | 3.62 | 3.62 | 3.28 | 5.75 | 5.3 | 4.99 | 4.31 | 8.12 | 6.97 | 10.58 | 3.42 | -3.42 | 10.56 |
| EBITDA
| 1,095.3 | 912.4 | 1,043.8 | 1,263 | 1,250.7 | 1,110.6 | 1,582.9 | 1,601.6 | 1,509.6 | 1,476.99 | 2,219.8 | 2,022.6 | 2,874.8 | 843.748 | -700.658 | 2,302.4 |
| EBITDA Ratio
| 0.107 | 0.085 | 0.109 | 0.125 | 0.117 | 0.098 | 0.137 | 0.123 | 0.13 | 0.116 | 0.173 | 0.166 | 0.253 | 0.124 | 0.103 | 0.202 |